Skip to main content

Fiscal Wizard · Single-issue tearsheet

SLNO / Jun 21, 2026 Run #7540

SLNO

Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California. As of May 18, 2026, Soleno Therapeutics, Inc. operates as a subsidiary of Neurocrine Biosciences, Inc.

Composite verdict

B 73.8 / 100
Bullish setup · Flow 10 drivers · 3 gates blocking
  • Chaikin Money Flow
  • Relative Strength vs SPY
  • Accumulation/Distribution Line
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 27th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: range
Bull 100%Evidence: High · 15 signals0% Bear
Momentum Bullish 99Mean-reversion Neutral 50

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -96%
Asset value $8.64Earnings power value $2.85Price $53.01

Priced above its no-growth earnings power value ($2.85/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Mixed

47.6 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Asset Turnover 90
Margin of Safety 0
Return on Assets 83
OCF to Net Income 0
Greenblatt ROC 82
Cash Conversion 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Chaikin Money Flow, Relative Strength vs SPY, Accumulation/Distribution Line); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Chaikin Money Flow 92
Relative Strength vs SPY 87
Accumulation/Distribution Line 82

Risk Gates

3 blocking 3 caution

3 guards active, 25 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for SLNO.